Mirotiv-2.5 2.5 mg Tablet

Mirotiv-2.5 2.5 mg tablet is manufactured and marketed by Renata PLC in Bangladesh. It contains Mirogabalin, one of the newer gabapentinoid medicines developed specifically for neuropathic (nerve-related) pain. It belongs to the same family as pregabalin and gabapentin and is available only on a doctor's prescription.

Nerve pain arises when damaged or irritated nerves fire pain signals excessively — felt as burning, tingling, electric-shock or pins-and-needles sensations. Mirogabalin binds tightly to the alpha-2-delta subunit of calcium channels on these overactive nerves, reducing the release of pain-transmitting chemicals. This quiets the abnormal signalling, easing pain gradually over days to weeks of regular use rather than instantly like an ordinary painkiller.

Mirotiv-2.5 is prescribed for peripheral neuropathic pain — pain caused by damaged nerves rather than by injury or inflammation of muscles and joints. Typical doctor-confirmed uses include:

• Painful diabetic peripheral neuropathy (burning or tingling feet and hands in diabetes)
• Post-herpetic neuralgia — persistent nerve pain after shingles (herpes zoster)
• Other peripheral nerve-pain conditions where a specialist finds a gabapentinoid appropriate

It is not intended for ordinary headaches, muscle aches or arthritis pain. Diagnosis matters: nerve pain should be confirmed by a doctor before this medicine is started, and the underlying cause — such as blood sugar control in diabetes — must be treated alongside.

The dose is individualised and adjusted by your doctor, especially according to kidney function:

• Starting: usually 5 mg twice daily
• Titration: increased in 5 mg steps at intervals of at least a week, as tolerated
• Usual maintenance: 10–15 mg twice daily
• Kidney impairment: needs reduced doses and slower increases — tell your doctor about any kidney problem

Mirotiv-2.5 can be taken with or without food, at roughly the same times each day. The benefit builds gradually, so take it regularly rather than only when pain is bad. Do not stop suddenly — taper over at least a week under medical advice to avoid rebound symptoms.

Most side effects relate to its calming action on the nervous system:

• Common: sleepiness, drowsiness, dizziness, unsteadiness, weight gain, swelling of the feet or ankles (oedema)
• Less common: blurred vision, constipation, dry mouth, difficulty concentrating, increased appetite
• Serious (contact a doctor): marked swelling with breathlessness, severe persistent dizziness with falls (especially in the elderly), unusual mood changes or distressing thoughts, allergic rash or facial swelling

Drowsiness and dizziness are strongest in the first one to two weeks and after dose increases — plan rest, avoid hazardous tasks and report troublesome effects so the dose can be refined rather than stopping abruptly on your own.

Key precautions while using Mirotiv-2.5:

• It is prescription-only — use it exactly as your specialist directs
• Avoid driving, riding motorcycles or operating machines until you know how drowsy or dizzy it makes you
• Elderly people are more prone to dizziness, falls and fractures — take extra care on stairs and during night-time walking
• Tell your doctor about kidney disease; doses must be lowered when kidney function is reduced
• Avoid alcohol and be cautious with other sedating medicines
• Watch your weight and report significant gain or new swelling
• Do not stop suddenly; taper according to your doctor's plan
• Report any unusual mood changes promptly

Mirogabalin has relatively few drug interactions because it is cleared mainly by the kidneys, but important ones remain:

• Sedating medicines — sleeping pills, benzodiazepines, opioid painkillers (such as tramadol), sedating antihistamines and antipsychotics add to drowsiness and unsteadiness
• Alcohol — significantly worsens sedation and balance; avoid it
• Other gabapentinoids (pregabalin, gabapentin) — should not be combined unless a specialist deliberately overlaps them during a switch
• Probenecid and certain drugs affecting kidney clearance — can raise mirogabalin levels

Always share your full medicine list, including diabetes medicines and supplements, with your doctor and pharmacist.

Mirotiv-2.5 should not be used in the following circumstances:

• Known allergy to mirogabalin or to any component of the tablet
• Previous serious allergic reaction (rash, swelling, breathing difficulty) to other gabapentinoids such as pregabalin or gabapentin — use only after specialist assessment
• Severe kidney failure, unless a doctor specifically adjusts the dose and monitoring plan
• Children and adolescents, in whom safety has not been established

Use it with special caution — and only under medical supervision — in the elderly, in people with a history of substance misuse, significant heart failure or severe respiratory disease.

Pregnancy: There is limited human data on Mirogabalin in pregnancy, so it is generally avoided unless the doctor decides the benefit clearly outweighs the unknown risks. If you are pregnant, planning pregnancy or discover pregnancy during treatment, inform your doctor promptly — and do not stop the tablets abruptly on your own.

Breastfeeding: It is not well established how much mirogabalin passes into human breast milk. Doctors usually prefer better-studied alternatives for nursing mothers, or advise monitoring the baby for excessive sleepiness and poor feeding if treatment is essential. Discuss feeding plans with your doctor before starting the medicine.

Store Mirotiv-2.5 in its original blister pack at room temperature below 30°C, away from direct sunlight, heat and moisture. Do not transfer tablets to open containers, and do not keep them in bathrooms or near cooking areas. Keep the medicine out of the reach and sight of children — its sedative effect makes accidental ingestion particularly risky for them. Check the expiry date before use, discard discoloured or damaged tablets, and dispose of leftover medicine safely instead of saving it for unsupervised use later.